Healthcare Services - Home and Alternate Site Infusion
Strategic Profile
Option Care Health has demonstrated robust revenue growth with a 3-year revenue growth rate of 15.1%, solid net margin of 3.78%, and EBITDA margin of 7.29%. The company is benefiting from the trend towards lower-cost home and ambulatory care settings, with increasing conversations with payer partners focused on reducing total care costs and improving clinical outcomes.
Cyborg Score Rationale
Option Care Health demonstrates a strong financial position with promising growth prospects, supported by solid revenue growth and profitability metrics. However, the transition to biosimilars and the associated revenue impact remains a concern, with expectations of further price reductions and competitive pressures. The company's strategic positioning in growing home-based care aligns with payer incentives.
Top Insights
Aggressive capital return with $1.0B buyback authorization and $307M repurchases in 2025
Expanding advanced practitioner model with 24 of 175 facilities capable of higher acuity operations, complementing pharmacy capabilities
Declining gross margin is a concern, with long-term decline averaging 1.3% per year